Le Lézard
Classified in: Health
Subject: PDT

Lofta Announces The Most Advanced Home Sleep Apnea Test on the Market


LA JOLLA, Calif., March 17, 2019 /PRNewswire-PRWeb/ -- Lofta, Inc., a San Diego based company revolutionizing the home sleep apnea test space announced a commercial agreement with Itamar Medical Ltd. which advances their revolutionary "Complete Path" home sleep apnea testing and treatment program.

Lofta will integrate Itamar's clinically validated diagnostic tool into their streamlined process. The Itamar Medical WatchPAT is a portable sleep diagnostic device that uses peripheral arterial tonometry to enable simple, and accurate testing without the complexity and discomfort of traditional airflow-based tests.

Sleep apnea is a serious condition that deprives the body and brain of much-needed oxygen, and can be a contributing factor to other serious conditions such as heart disease, type 2 diabetes, adult asthma, acid reflux and weight gain.

Lofta brings the most advanced home sleep apnea test on the market to its clients using Itamar Medical's WatchPAT. The Lofta Complete Path takes clients from sleep apnea diagnosis, to sleep apnea treatment in as little as 5-days all from the comfort of home.

CEO, Jay Levitt explains;

"A desire to provide a simple, accurate, reliable solution to those struggling with sleep-disordered breathing and sleep apnea drove the decision to use Itamar's WatchPAT technology. Lofta is committed to making the sleep apnea diagnosis process accessible, and simple to everyone through advanced technology, and a user-friendly approach that has been clinically validated against polysomnography."

"Historically, the process of getting diagnosed and treated for sleep apnea has been challenging for patients who often avoid over-night sleep labs that contribute to the complexity and cost of an already difficult journey. Unfortunately, this means people who have a potentially life-threatening condition go undiagnosed, and untreated."

"Lofta clears the way to better sleep by providing access to sleep apnea screening, testing, online diagnosis and comprehensive treatment support all from one place - the client's home."

Levitt continues, "The WatchPAT is a great match for our clients looking for something quick, easy, and hassle-free. Unlike other sleep tests that require nasal tubes and multiple components, Itamar's device is as easy as putting on a wrist watch. With this in mind, we think it's the perfect tool for Lofta's Complete Path program."

Despite Lofta's commitment to ease and convenience, the company is also committed to all professional best practices, and the highest level of client success, and support.

Lofta's Director of Client Services, Laura Avilez, explains;

"Sleep apnea is a serious condition and should be treated. For this reason, the medical aspects of the Lofta Complete Path are overseen by independent board-certified sleep physicians. We aren't your typical home sleep apnea testing company that ships out tests with little guidance or support. We stay with our clients every step of the way. We love Itamar's WatchPAT because its advanced technology provides quick comprehensive test results. And, our clients appreciate that we can explain the results of their study in a thorough, and accessible way. When people are better informed about their condition, they are vested in their therapy outcomes."

Along these lines, Levitt points out the distinctive aspect of Lofta's business model, which he believes will be enhanced by the Itamar technology, "Lofta's objective is to create long-time relationships with clients by making better sleep easy, and accessible."

About Lofta

Lofta is redefining how people are diagnosed and treated for sleep apnea and chronic snoring with life changing results. By leveraging telemedicine technology, one-on-one customer service, and a consumer-centric approach, Lofta offers sleep apnea testing and treatment solutions on pace with the rapidly changing health and wellness environment - when and where clients need them the most.

Motivated by a desire to streamline the complex process of sleep testing, Lofta makes a better night sleep accessible quickly and easily by removing the obstacles that compound an already exhausting problem - the maze of insurance requirements, inconvenient overnights at a sleep lab, and an all-too-common lack of support - Lofta clears the way to healthy sleep.

Lofta's Complete Path is only part of the company's story. Lofta also seeks to cultivate enduring relationships through its innovative high touch therapy program featuring dedicated sleep coaches and one-on-one support at every step.

As clients continue their treatment journey, Lofta leverages advanced technology to report sleep outcomes daily, and in real-time providing a continuous feedback loop to optimize ongoing therapy. Through high-tech, high-touch engagement, Lofta clients achieve long-term sleep wellness.

All Lofta's signature programs, including its comprehensive e-commerce experience, are available at Buyminicpap.com, and in early 2019 Lofta will launch its new web experience at Lofta.com.

 

SOURCE Lofta


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: